Idebenone is a new benzoquinone derivative that has been reported to have protective and improving actions on neurological disorders due to experimental cerebral hypoxia or ische mia (1, 2) . Idebenone has been reported to prevent a decrease in the ATP content in the rat ischemic brain (3); and furthermore, it has been shown to stimulate the ATP production in isolated rat brain mitochondria (4) . Its effect on the contents and turnover of neuro transmitters has also been previously tested. The reduced levels of acetylcholine content and serotonin turnover in the rat brain with experimental ischemia have been reported to be normalized by the administration of idebenone, but the metabolism of norepi nephrine and dopamine in the rat brain has been shown to be not significantly affected by this agent (5, 6) . In contrast to the in vivo stu dies, we have recently shown that the forma tion of [14C]catecholamines from [14C]tyrosine in cultured bovine adrenal chromaffin cells is significantly enhanced by idebenone, and this enhancement of [14C]catecholamine produc tion may result from the enhancement of the [14C]tyrosine supply to the catecholamine biosynthetic pathway within these cells (7) . Thus, it may be fair to say that the question of whether idebenone may be able to modulate the function of the sympathoadrenergic system
has not yet been completely elucidated. To obtain information on this subject, in the pres ent study, the effect of idebenone on catechol amine secretion was examined using primary cultured bovine adrenal chromaffin cells as a model of the sympathoadrenergic neuron. Idebenone was shown to inhibit the secretory response by blocking the influx of extracellular Ca 2+ into the cells.
METERIALS AND METHODS

Cell preparation and culture
Chromaffin cells were enzymatically pre pared from fresh bovine adrenal medulla according to the previously described method (8) . Isolated cells were plated on 24-well plas tic cluster plates at a density of 5 X 105 cells/well, and maintained for 3 or 4 days as monolayer cultures at 37°C in a humidified atmosphere containing 5% CO2 in 1.5 ml of Eagle's minimum essential medium containing 5% heat-inactivated newborn calf serum, 2 mM glutamine, 100 U/ml of penicillin, 100 ,ug/ml of streptomycin, 50,ug/ml of gentami cin, 2,ug/ml of fungizone, and 10-5 M cyto sine arabinoside.
Determination of catecholamine secretion Cells were washed with 1 ml of balanced salt solution [135 mM NaCI, 5.6 mM KCI, 1.2 MM MgCl2, 2.2 mM CaC12, 10 mM glucose, and 20 mM 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), adjusted to pH 7.4], and then stimulated by various secretago gues at 37°C for 10 min in 250,ul of balanced salt solution containing various concentrations of the test compounds. At the end of the in cubation period, the medium was withdrawn, and the cells were lysed by adding 250 ,u 1 of 10% acetic acid, followed by a freeze-thawing cycle. The amounts of catecholamines in the medium and the lysate were determined as de scribed previously (9, 10), and catecholamine secretion was then calculated as the percent age of total cellular catecholamine content se creted during the incubation period.
Determination of Ca2+ influx
Cells were washed and then incubated with secretagogues at 37°C for 10 min in 250 ,u l of balanced salt solution containing 45CaC12 (3 ,aCi/ml) with or without the test compound. At the end of the incubation period, the medium was removed by aspiration, the cells were washed 4 times with 1 ml of ice-cold Ca2+-free balanced salt solution, and the cells were then solubilized by adding 500,ul of 1% Triton X-100. Radioactivity in the cell lysate was counted by a liquid scintillation spectrom eter. The Ca 2+ uptake was calculated on the basis of the specific activity of 45Ca2+ in the incubation mixture.
The concentration of NaCI in the high K+ medium was reduced to keep the solution iso tonic. In the Bat+-containing salt solution, CaC12 was substituted by an equimolar of BaCl2. The final concentration of dimethylsul foxide utilized to dissolve the hydrophobic test compounds was less than 1%, which did not have any notable effect on catecholamine secretion and Ca 2+ influx.
The standard error (S.E.) of the difference between two groups was calculated as (S.E.,2 + S.E.22)1/2, as described previously (11) ; and Student's t-test was used to determine statistic al significance.
Chemicals 45CaCl 2 was purchased from New England Nuclear. Acetylcholine, nifedipine, veratri dine, and A23187 were from Sigma Chemical Co. The cerebral metabolism-improving agents tested here were kindly donated by Takeda Chemical Industries, Ltd.
(idebenone), Tanabe Seiyaku Co., Ltd. (calcium hopanten ate), and Hoechst Japan, Ltd. (propentofyl line). Other chemicals were of commercially available reagent grades.
RESULTS
The effects of various cerebral metabolism improving agents on catecholamine secretion were first examined using cultured bovine adrenal chromaffin cells. As shown in Table 1, idebenone (104 M) markedly inhibited the catecholamine secretion evoked by acetylcho line. Neither hopantenate nor propentofylline had any notable effect on the secretion at the same concentrations. Next, we performed further studies on the effect of idebenone on the secretory response. The inhibitory action of idebenone on the acetylcholine-evoked secretion was observed in a concentration-de pendent manner at concentrations higher than 10-6 M, whereas the basal level of the secre tion was not significantly influenced by the agent in the same concentration range (Fig.  1 ). This inhibitory action on the acetylcholine evoked secretion was not overcome by elevat ing the concentration of acetylcholine in the reaction mixture (data not shown). The effect of idebenone on the secretory response to a different type of secretagogue was also tested. As shown in Fig. 2 , catecholamine secretion evoked by high K+ (56 mM K+), veratridine (2 X 10-5 M), or Ba2+ (2 mM) was inhibited by idebenone, but the secretion evoked by A23187 (10-5 M) was not significantly altered by this agent. Thus, idebenone was shown to inhibit catecholamine secretion from cultured adrenal chromaffin cells probably through its inhibitory action on the Ca 2+ influx into the cells.
To test the effect of idebenone on the pro cess of Ca 2+ influx, the accumulation of 45Ca2+ within the cells was determined in the presence and absence of this agent. The up take of 45Ca2+ into the cells stimulated by high K+ as well as acetylcholine was marked ly inhibited by idebenone (10-4 M) under the conditions in which the inhibition of catechol amine secretion by this agent was observed (Fig. 3) . The effect of a voltage-dependent Ca 2+ channel blocker, nifefipine, on the secretory response was furthermore examined in the presence and absence of idebenone. Nifedipine alone (10-5 and 10-4 M) markedly inhibited catecholamine secretion evoked by high K+, but this inhibitory action was dra matically diminished by the presence of idebenone (10-5 M) which produced about a 40% inhibition of the high K+-evoked secre tion under the experimental conditions used here (Fig. 4) . These results suggested the pos sibility that idebenone might be able to inhibit the influx of Ca 2+ into the cells presumably through its blocking action on the site that is also blocked by nifedine, thus resulting in the inhibition of catecholamine secretion evoked by different secretagogues in cultured bovine adrenal chromaffin cells. cells (7) . In addition, the present study also indicated that this agent inhibited the catechol amine secretion evoked by acetylcholine at a concentration similar to that required to stimulate catecholamine production as re ported previously. Thus, idebenone was shown to have an ability to modulate adrenergic cell functions. In addition to the finding that the inhibitory action of this agent on catechol amine secretion was not affected by changing the concentration of acetylcholine in the in cubation mixture, idebenone was shown to in hibit the secretion evoked by depolarization of the plasma membrances as well as stimulation of the nicotine acetylcholine receptors. In con trast, this agent failed to inhibit the secretion evoked by a Ca 2+-ionophore which is well known to stimulate the intracellular secretory system as a consequence of introducing Ca 21 into the cells. Therefore, these findings seem to indicate that idebenone inhibits catechol amine secretion presumably through its block ing action on the transport of Ca 2+ across the plasma membranes rather than by acting on nicotinic acetylcholine receptors or disturbing the Ca2+-activated secretory mechanism with in the cells. In addition to these observations, idebenone was also shown to inhibit catecholamine secre tion evoked by Ba2+ in cultured bovine adrenal chromaffin cells. Since Ba2+ is well established to evoke catecholamine secretion from adrenal medulla even in the absence of extracellular Ca2+, the inhibitory action of this agent on the Ba2+-evoked secretion was thought to be unrelated to its action on the Ca 2+ channels. However, Ba2+ has recently been found to enter the cells through voltage dependent Ca 2+ channels and also shown to evoke catecholamine secretion as a result of stimulating directly the Ca 2+-activited secre tory mechanism within the cells (12) (13) (14) . It therefore seems conceivable that idebenone may cause the inhibition of Ba2+ entry into the cells, probably through its blocking action on voltage-dependent Ca 2+ channels, result ing in the inhibition of the Ba2+-evoked secre tion observed here.
The effect of idebenone on the influx of Ca 2+ into chromaffin cells was further studied by determining the accumulation of radio active Ca 2+ within the cells, and the Ca 2+ in flux stimulated by either acetylcholine or high K+ was markedly inhibited by the agent under the conditions in which its inhibitory action on the secretion was observed. Thus, idebenone was confirmed to inhibit catechol amine secretion by blocking the influx of Ca2+ into the cells. However, it still remains to be elucidated whether the Ca 2+ influx inhibited by this agent may be mediated by voltage-de pendent Ca2+ channels or not. To solve this question, the influence of idebenone on the inhibitory action of nifedipine on catechol amine scretion evoked by high K+ was then tested. Nifedipine was shown to inhibit catecholamine secretion evoked by high K+ due to the blockade of voltage-dependent Ca 2+ channels, but this inhibitory action on the secretion was markedly decreased or almost completely abolished by the presence of idebenone. The inhibitory action of nife dipine on the high K+-evoked secretion ap peared to be antagonized by idebenone. It therefore seems possible to assume that the site(s) inhibited by idebenone may be the same or tightly coupled with that blocked by nifedipine. Thus, idebenone is considered to inhibit Ca 2+ influx into the cells, leading to the inhibition of catecholamine secretion, pre sumably through its blocking action on voltage-dependent Ca2+ channels.
In the present study, idebenone was shown to inhibit catecholamine secretion as a con sequence of blocking the Ca 2+ influx into cul tured bovine adrenal chromaffin cells, and this inhibition was suggested to be attributed to the inhibition of voltage-dependent Ca 2+ channels. It is thus reasonable to consider the possibility that idebenone may cause the dila tion of cerebral blood vessels in situ, presum ably through its inhibitory action on neuro transmitter release from the sympathoad renergic nerve and its blocking action on the Ca 2+ influx into the vascular smooth muscle. As a possible mechanism of the improving ac tion of idebenone on cerebral metabolism, the inhibition of voltage-dependent Ca 2+ channels by this agent in the adrenergic nerve ending as well as the blood vessel is proposed here, but conclusive evidence supporting this possible mechanism must still be obtained.
